Form 4: Orthofix Director Jason Hannon Acquires Shares and Holds Deferred Stock Units

Director Jason Hannon acquired 15,152 shares of Orthofix Medical Inc. common stock at $12.87 per share on June 18, 2024, and holds 44,790 deferred stock units.

Summary

• On June 18, 2024, Jason Hannon, a director of Orthofix Medical Inc., acquired 15,152 shares of common stock at a price of $12.87 per share.
• This acquisition was reported on a Form 4 filing with the SEC.
• Following the transaction, Hannon directly owns 49,364 shares, which includes 44,790 deferred stock units.
• The deferred stock units vest in full on the first anniversary of the grant date, contingent upon Hannon's continued service.
• Vested deferred stock units will settle and convert into common stock within 45 days of Hannon's termination of service with the issuer.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a standard transaction by a company director. The acquisition of shares could be seen as a positive signal, but it's a relatively small transaction.

Positives

• The acquisition of shares by a director may signal confidence in the company's future prospects.

Future Outlook

The deferred stock units will vest on the first anniversary of the grant date, contingent upon continued service, and will convert to common stock within 45 days post-termination of service.

Industry Context

This is a standard SEC Form 4 filing, indicating a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company directors and officers.

Stakeholder Impact

• The acquisition of shares by a director could have a minor positive impact on shareholder confidence.

Key Dates